Rothschild Investment LLC’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-294
| Closed | -$18K | – | 1362 |
|
|
2023
Q3 | $18K | Sell |
294
-125
| -30% | -$7.65K | ﹤0.01% | 476 |
|
|
2023
Q2 | $43K | Sell |
419
-370
| -47% | -$38K | ﹤0.01% | 485 |
|
|
2023
Q1 | $139K | Sell |
789
-850
| -52% | -$150K | 0.01% | 454 |
|
|
2022
Q4 | $634K | Buy |
1,639
+31
| +2% | +$12K | 0.06% | 257 |
|
|
2022
Q3 | $542K | Buy |
1,608
+180
| +13% | +$60.7K | 0.05% | 269 |
|
|
2022
Q2 | $469K | Hold |
1,428
| – | – | 0.04% | 305 |
|
|
2022
Q1 | $625K | Buy |
1,428
+70
| +5% | +$30.6K | 0.05% | 288 |
|
|
2021
Q4 | $596K | Hold |
1,358
| – | – | 0.05% | 299 |
|
|
2021
Q3 | $756K | Buy |
1,358
+319
| +31% | +$178K | 0.06% | 247 |
|
|
2021
Q2 | $534K | Sell |
1,039
-44
| -4% | -$22.6K | 0.04% | 314 |
|
|
2021
Q1 | $847K | Buy |
1,083
+72
| +7% | +$56.3K | 0.07% | 236 |
|
|
2020
Q4 | $551K | Buy |
1,011
+100
| +11% | +$54.5K | 0.05% | 272 |
|
|
2020
Q3 | $417K | Buy |
911
+55
| +6% | +$25.2K | 0.05% | 285 |
|
|
2020
Q2 | $527K | Buy |
856
+128
| +18% | +$78.8K | 0.06% | 240 |
|
|
2020
Q1 | $346K | Sell |
728
-11
| -1% | -$5.23K | 0.05% | 294 |
|
|
2019
Q4 | $429K | Hold |
739
| – | – | 0.04% | 313 |
|
|
2019
Q3 | $486K | Sell |
739
-89
| -11% | -$58.5K | 0.06% | 255 |
|
|
2019
Q2 | $641K | Buy |
828
+236
| +40% | +$183K | 0.08% | 220 |
|
|
2019
Q1 | $418K | Sell |
592
-14
| -2% | -$9.89K | 0.05% | 272 |
|
|
2018
Q4 | $283K | Sell |
606
-30
| -5% | -$14K | 0.04% | 298 |
|
|
2018
Q3 | $548K | Buy |
636
+8
| +1% | +$6.89K | 0.06% | 229 |
|
|
2018
Q2 | $433K | Buy |
628
+9
| +1% | +$6.21K | 0.05% | 250 |
|
|
2018
Q1 | $276K | Buy |
619
+222
| +56% | +$99K | 0.04% | 314 |
|
|
2017
Q4 | $175K | Buy |
+397
| New | +$175K | 0.02% | 389 |
|